A novel primary immune deficiency caused by homozygous GIMAP6 variants in two siblings
A new article published in the European Journal of Human Genetics describe the first documented human cases of a homozygous deleterious GIMAP6 variant in the GIMAP6 gene. Patients demonstrated accelerated apoptosis, but largely normal lymphocyte subpopulations, activation and proliferation and cytokine release. There appears to be a spectrum of clinical features associated with deficiency of GIMAP6 protein, with one patient suffering lymphopenia and recurrent sinopulmonary infections, and the other clinically asymptomatic. This study emphasizes the utility of next-generation sequencing in extending our understanding of primary immune deficiency
- Eur J Hum Genet . 2021 Apr;29(4):657-662